AGA Nanotech Joins HTCC Accelerator Programme

AGA Nanotech is excited to announce our selection for the Healthcare Technologies Capabilities Connector (HTCC) SME Accelerator Programme. This competitive programme is designed to support the development of healthcare, biotech, and MedTech innovations and is supported by Research England. The HTCC SME Accelerator is a collaborative initiative run in partnership between the University of Hertfordshire, Imperial College London, and Cranfield University. It provides a comprehensive support package that includes access to a designated postgraduate researcher, academic, technical, and industry experts to help accelerate product evelopment. Quote: “We are thrilled to be part of the HTCC Accelerator Programme. This opportunity will provide us with invaluable resources and expertise to further develop and refine our Battlestar technology,” said Harsha Siani, CEO of AGA Nanotech.

AGA Nanotech will collaborate with Dr. Simon Baines and Laura Thomas from the University of Hertfordshire, who are experts in antimicrobial resistance (AMR), microbiology, and cell biology. Their expertise will be instrumental in further evaluating and advancing our Battlestar technology, ensuring its efficacy and safety for potential clinical applications. We look forward to the collaborative efforts and the positive impact this programme will have on fast tracking our technology.